Header Logo

Connection

ELIZABETH A LANO to von Hippel-Lindau Disease

Back to Details
This is a "connection" page, showing publications ELIZABETH A LANO has written about von Hippel-Lindau Disease.
ELIZABETH A LANO
Connection Strength
0.074
von Hippel-Lindau Disease
  1. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab. 2009 Feb; 94(2):386-91.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.